Following 2010 and 2011 charitable campaigns in which DavidBartonGym raised over $200,000 to improve treatment options for women with ovarian cancer, gym founder and owner David Barton will proclaim for a third consecutive year September 20, 2012 as “Diane’s Day” in honor of Barton’s sister, Diane Barton. All DavidBartonGym locations in New York, Chicago, Miami, Las Vegas, Los Angeles and Seattle will donate proceeds from every personal training session on Diane’s Day to The Clearity Foundation and Ovarian Cancer Research Fund.
The Clearity Foundation optimized DavidBartonGym’s financial contributions in 2010 and 2011 by creating the Diane Barton Database, a valuable and accessible platform to help women make better treatment decisions. By comparing each woman’s individual molecular profiling data against the Diane Barton Database, treatment choices can be personalized and prioritized.
“Ovarian cancer is hard to detect but harder to treat. For the last three years, I have partnered with an organization whose research benefits people right now and who need additional funding to continue to make improvements in treatment and detection. Every penny gets us one step closer to improving someone’s chances. I can’t emphasize enough the importance of acting now,” said David Barton, founder of DavidBartonGym.
“Thanks to the money raised by DavidBartonGym, The Clearity Foundation has improved its database of tumor “blueprints” and named it the Diane Barton Database, in honor of David’s sister, a physician who was only 45 years old when she passed away,” said Laura Shawver, Ph.D., Founder of The Clearity Foundation. “David is deeply committed to providing women with ovarian cancer resources that can positively impact their lives today. At The Clearity Foundation we offer resources to do just that.”
Ovarian cancer tumors vary from patient to patient and do not uniformly respond to FDA-approved treatment; therefore they need customized treatment plans. Molecular profiling enables the individualization of a patient’s treatment by matching tumor alterations with one or more drugs.
“OCRF is committed to advancing ovarian cancer research. From learning how, why and where ovarian cancer originates, grows and spreads and discovering more blood markers that could provide better early detection methods, to boosting the body’s immune system and identifying targeted new drug therapies to fight it, Ovarian Cancer Research Fund is on the cusp of a rush of scientific discovery. We are so grateful to DavidBartonGym for supporting us at this crucial time,” said Audra Moran, OCRF CEO.
DavidBartonGym will be partnering with Sir Alistair Rai, an accessories company founded by designer Kiran Rai, who strives to base her business on honoring truth and social consciousness on a day-to-day basis. Rai’s scarves will be sold at the gym throughout the entire month of September and 100% of the proceeds will go to The Clearity Foundation as well as the Ovarian Cancer Research Fund. (Peacock Handkerchief: $40, Destination Maldive Mantra Wrap: $75, www.siralistairrai.com).
Founded in 1992 in Chelsea, New York and celebrating 20 years in business in Summer 2012, DavidBartonGym has hand-picked equipment, personally mentored trainers with a tradition of changing bodies and award-winning design. With locations in New York, Miami, Chicago, Las Vegas, Los Angeles and Seattle, gym innovator David Barton promises to have members that “LookBetterNaked.” www.davidbartongym.com
About The Clearity Foundation
The mission of The Clearity Foundation is to improve treatment options for women with ovarian cancer and change the one-size-fits-all approach in order to improve survival. Ovarian cancer is a complex, heterogeneous disease where most all women receive standard treatment, regardless of the histology or the molecular biology of their tumors. Ovarian cancer kills more than 15,000 women every year out of the approximately 21,000 diagnosed. When a patient’s ovarian cancer returns after standard chemotherapy, a chance for a cure is less than 15%, or less than 3% if she did not respond to initial treatment. The Clearity Foundation is a 501(c)(3) not-for-profit organization founded by an ovarian cancer survivor and scientist. www.clearityfoundation.org.
About Ovarian Cancer Research Fund
Ovarian Cancer Research Fund (OCRF) is the largest private non-profit organization in the United States dedicated exclusively to funding ovarian cancer research. OCRF supports scientific research on ovarian cancer that leads to more effective identification, treatment, and ultimately a cure for ovarian cancer, as well as related educational and support initiatives. Each year there will be over 22,000 new cases of ovarian cancer in the United States, and approximately 15,500 women will die of the disease. Currently there is no effective means of early detection. Since 1998, OCRF has awarded nearly $45 million in grants for ovarian cancer research. Thanks to the generosity of our donors, OCRF-sponsored researchers are developing innovative strategies for early detection; exploring the genetics that increase risk for ovarian cancer; understanding the underlying molecular biology of the disease; identifying new and better targets for treatment; and deciphering how and why ovarian cancer spreads, and how to stop it. www.ocrf.org.